Skip to search.
 FTSE 100 Up 1.31%

MannKind Corporation (MNKD)

-NasdaqGM
0.64 Up 0.06(10.42%) 6 Dec 21:00
|Pre-Market : 0.64 Down 0.00 (0.50%) 10:23 - Nasdaq Real Time Price
Prev Close:0.58
Open:N/A
Bid:0.62 x 100
Ask:0.64 x 100
1y Target Est:0.15
Beta:2.84039
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.41 - 2.24
Volume:10,100
Avg Vol (3m):3,947,790
Market Cap:307.64m
P/E (ttm):N/A
EPS (ttm):-0.46
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for MNKD at this time.

Comparison

Symbol% ChgMkt Cap
MNKDUp 10.42%307.64m
LLYUp 0.80%71.55b
GSKUp 0.05%89.81b
NVOUp 2.44%89.84b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.11
Quarterly EPS Est (Dec-16) :-0.04
Mean Recommendation*:4.0
PEG Ratio (5 yr expected):0.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes patients in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback